Bis(2,2-dimethyl-1-aziridinyl)phosphinic amides for use in the t

Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D20306, A61K 31395

Patent

active

045445010

ABSTRACT:
Novel bis(2,2-dimethyl-1-aziridinyl)phosphinic amide antineoplastic agents are disclosed of the formula: ##STR1## wherein R and R' are each, independently, hydrogen, alkyl, substituted alkyl, phenyl and substituted phenyl and, Z is oxygen or sulfur.

REFERENCES:
patent: 3201313 (1965-08-01), Bardos et al.
Lalka et al., J. Pharm. Science, 62(8) (1973), pp. 1294-1298.
Chem. Abstracts 67:21748y (1967).
Chernov et al., Chem. Abstracts, vol. 62, (1965), Abst:15243d.
Orrie et al., Chem. Abstracts, vol. 59, (1963), Abst:6337a.
Wodinsky et al., Combined Therapy with an Aziridine Derivative NSC 200724 (Ab182) and Radiation on an Experimental Leukemia, Int. J. Radiation Oncology Biol. Phys., vol. 5, pp. 1677-1680, 1979.
Hsiao et al., Synthesis of New Bis(1-Aziridinyl)Phosphinate Alkylating Agents Containing O-Phenyl N-Phenylcarbamate Side Chains, Jour. of Med. Chem., vol. 16, p. 391, 1973.
Wampler et al., Absence of Cross-Resistance to Alkylating Agents in Cyclophosphamide-Resistant L1210 Leukemia, Europ. J. Cancer, vol. 14, pp. 977-982, 1978.
Bardos et al., Synthesis of Potential Dual Antagonists III, Jour. of Pharmaceutical Sciences, vol. 54, No. 2, Feb., 1965.
Chmielewicz et al., Synthesis and Chemotherapeutic Effects of Ethyl Bis-(2,2-Dimethyl)-Ethylenamido Phosphate. A Preliminary Report, Jour. of Pharmaceutical Sciences, vol. 56, No. 9, Sep. 1967.
Bardos et al., Structure-Activity Relationships of Alkylating Agents in Cancer Chemotherapy, Annals of The New York Academy of Sciences, vol. 163, Article 2, pp. 1006-1025, Oct. 3, 1969.
Chmielewicz et al., Alterations of Some Macromolecular and Biochemical Properties of Calf Thymus DNA Caused by "Dual Antagonists" and Nitrogen Mustard, Cancer Research, 27, pp. 1248-1257, Jul. 1967.
Munson et al., Preparation and Antitumor Activity of Tris(2,2-Dimethyl-1-Aziridinyl)Phosphine Oxide (TEPA-132), Cancer Chemotherapy Reports, vol. 51, No. 5, pp. 253-259, Sep. 1967.
Bardos et al., Effects of Ring-C-Methyl Substituents on the Chemical and Biological Activities of Ethylenimine Type Alkylating Agents, Int. Congress of Chemotherapy, Jun. 1967.
Bardos, Antimetabolites: Molecular Design and Mode of Action, Topics in Current Chemistry, vol. 52, pp. 90 and 91 only, 1974.
Lalka et al., Cyclophosphamide, 2,2-Dimethyl-Aziridines and Other Alkylating Agents as Inhibitors of Serum Cholinesterase, Biochemical Pharmacology, vol. 24, pp. 455-462, 1975.
Lalka et al., Reactions of 2,2-Dimethyl-Aziridine-Type Alkylating Agents in Biological Systems II: Comparative Pharmacokinetics in Dogs, Jour. of Pharmaceutical Sciences, vol. 64, No. 2, Feb., 1975.
Bardos et al., Chemical Mechanism of the Radiation Potentiating Effects of 2,2-Dimethylaziridine-Type Antitumor Agents, Int. J. Radiation Oncology Biol. Phys., vol. 5, pp. 1653-1656, 1979.
Wampler et al., Radiation Potentiating Effect of Ethyl Bis(2,2-Dimethyl-1-Aziridinyl)Phosphinate (AB-163), Int. J. Radiation Oncology Biol. Phys., vol. 5, pp. 1681-1683, 1979.
Hsiao et al., Synthesis of 5'-Thymidinyl Bis(1-Aziridinyl)Phosphinates as Antineoplastic Agents, Jour. of Med. Chemistry, vol. 24, pp. 887-889, 1981.
Zhdanov et al., Biologically Active Stable Radicals; XV.sup.1. Spin-Labeled Alkyl Carbamate-N-Phosphonic Acid Aziridides, "Synthesis", pp. 269-271, 1979.
Konieczny et al., Methods for the Preparation of Spin-Labeled Phosphorus Compounds and Applications of Some of Them to Phosphorylative Spin-Labeling, "Synthesis", Sep. 1981.
Kimler et al., Development and Testing of New Hypoxic Cell Radiosensitizers, Radiology, vol. 33, pp. 515-517, 1979.
Bardos et al., Synthesis of Potential Dual Antagonists IV, Jour. of Pharmaceutical Sciences, vol. 54, No. 3, Mar., 1965.
Hsiao et al., Synthesis of Bis(Aziridinyl)Phosphinyl-N-Hydroxy-Urethane Derivatives as Antineoplastic Agents, Jour. of Medical Chemistry, vol. 18, p. 195, 1975.
Bardos et al., Combination of Chemotherapy with Dual Antagonists and Radiotherapy in the Treatment of Neoplastic Disease, Journal of Surgical Oncology 3(4); pp. 431-441, 1971.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Bis(2,2-dimethyl-1-aziridinyl)phosphinic amides for use in the t does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bis(2,2-dimethyl-1-aziridinyl)phosphinic amides for use in the t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis(2,2-dimethyl-1-aziridinyl)phosphinic amides for use in the t will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1441062

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.